Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression

被引:43
|
作者
Yang, Xiao [1 ,2 ,3 ]
Ma, Xiaojuan [4 ]
Huang, Bin [5 ]
Sun, Guizhi [6 ]
Zhao, Liansheng [1 ,2 ,3 ]
Lin, Dongtao [7 ]
Deng, Wei [1 ,2 ,3 ]
Li, Tao [1 ,2 ,3 ]
Ma, Xiaohong [1 ,2 ,3 ]
机构
[1] Sichuan Univ, Psychiat Lab, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Dept Psychiat, West China Hosp, Chengdu 610041, Peoples R China
[3] Sichuan Univ, Natl Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China
[4] Chengdu First Peoples Hosp, Chengdu 610041, Peoples R China
[5] Dong Feng Mao Jian Hosp, Shiyan 442012, Peoples R China
[6] Binzhou Med Univ Hosp, Binzhou, Peoples R China
[7] Sichuan Univ, Coll Foreign Languages & Cultures, Chengdu 610064, Sichuan, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
VOXEL-BASED MORPHOMETRY; COGNITIVE DEFICITS; NEUROPSYCHOLOGICAL IMPAIRMENTS; NEUROCOGNITIVE IMPAIRMENT; UNIPOLAR DEPRESSION; NEURAL CIRCUITRY; DISORDER; METAANALYSIS; REDUCTION; MEMORY;
D O I
10.1016/j.comppsych.2015.09.003
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Impaired sustained attention seems to be a core feature of depression while the anatomical alteration of brain was widely reported in depression patients. The authors aimed to identify the relationship between anatomical brain changes and sustained attention deficits in unmedicated patients with major depressive disorder (MDD). Methods: A total of 51 medication-free MDD patients and 51 matched healthy controls (HC) underwent high-resolution structural magnetic resonance imaging scanning, and optimized voxel-based morphometry method was performed to analyze the changes of gray matter volume (GMV). We employed a computerized neurocognitive task from the Cambridge Neuropsychological Tests Automated Battery (CANTAB) - Rapid Visual Information Processing (RVP) task as a measurement of sustained attention. Based on clinical symptoms, 40 patients who had completed CANTAB-RVP test were divided into MDDa (mild depression patients) and MDDb (severe depression patients) groups. Then the relationships among sustained attention, GMV of different regions and clinical symptoms were explored separately. Results: MDD patients showed significant GMV increase in left posterior cingulate cortex (PCC) and inferior frontal gyms (IFG) (p < 0.001, uncorrected), and significant GMV decrease in medial/superior frontal gyms (MFG/SFG) and lingual gyms (p < 0.001, uncorrected). Structure cognition correlation analyses revealed that in MDD patients, GMV alterations of the IFG were significantly correlated with sustained attention as measured by the CANTAB-RVP. Conclusions: Increased GMV values of IFG were associated with sustained attention which may underlie the pathophysiology of MDD or be part of the cognition circuit. In the severe depression patients, sustained attention deficits were positively correlated with clinical symptoms. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 50 条
  • [21] Localized gray matter volume abnormalities in generalized anxiety disorder
    Schienle, Anne
    Ebner, Franz
    Schaefer, Axel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2011, 261 (04) : 303 - 307
  • [22] Regional gray matter volume abnormalities in the at risk mental state
    Borgwardt, Stefan J.
    Riecher-Roessler, Anita
    Dazzan, Paola
    Chitnis, Xavier
    Aston, Jacqueline
    Drewe, Margret
    Gschwandtner, Ute
    Haller, Sven
    Pflueger, Marlon
    Rechsteiner, Evelyne
    D'Souza, Marcus
    Stieglitz, Rolf-Dieter
    Radu, Ernst-Wilhelm
    McGuire, Philip K.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (10) : 1148 - 1156
  • [23] Gray matter abnormalities associated with duration of untreated psychosis
    Lappin, JM
    Morgan, K
    Morgan, C
    Hutchison, G
    Chitnis, X
    Suckling, J
    Fearon, P
    McGuire, PK
    Jones, PB
    Leff, J
    Murray, RM
    Dazzan, P
    SCHIZOPHRENIA RESEARCH, 2006, 83 (2-3) : 145 - 153
  • [24] Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression
    Abe, Osamu
    Yamasue, Hidenori
    Kasai, Kiyoto
    Yamada, Haruyasu
    Aoki, Shigeki
    Inoue, Hideyuki
    Takei, Kunio
    Suga, Motomu
    Matsuo, Koji
    Kato, Tadafumi
    Masutani, Yoshitaka
    Ohtomo, Kuni
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2010, 181 (01) : 64 - 70
  • [26] Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects
    Neumeister, A
    Wood, S
    Bonne, O
    Nugent, AC
    Luckenbaugh, DA
    Young, T
    Bain, EE
    Charney, DS
    Drevets, WC
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 935 - 937
  • [27] Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression
    Frodl, T.
    Koutsouleris, N.
    Bottlender, R.
    Born, C.
    Jaeger, M.
    Moergenthaler, M.
    Scheuerecker, J.
    Zill, P.
    Baghai, T.
    Schuele, C.
    Rupprecht, R.
    Bondy, B.
    Reiser, M.
    Moeller, H-J
    Meisenzahl, E. M.
    MOLECULAR PSYCHIATRY, 2008, 13 (12) : 1093 - 1101
  • [28] Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression
    T Frodl
    N Koutsouleris
    R Bottlender
    C Born
    M Jäger
    M Mörgenthaler
    J Scheuerecker
    P Zill
    T Baghai
    C Schüle
    R Rupprecht
    B Bondy
    M Reiser
    H-J Möller
    E M Meisenzahl
    Molecular Psychiatry, 2008, 13 : 1093 - 1101
  • [29] Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression
    Ajilore, Olusola
    Narr, Katherine
    Rosenthal, Jonah
    Pham, Daniel
    Hamilton, Liberty
    Watari, Kecia
    Elderkin-Thompson, Virginia
    Darwin, Christine
    Toga, Arthur
    Kumar, Anand
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2010, 184 (02) : 63 - 70
  • [30] Decreased fronto-limbic gray matter volume associated with recurrent major depressive disorder
    Arnone, D.
    Pegg, E. J.
    McKie, S.
    Downey, D.
    Elliott, R.
    Williams, S. R.
    Deakin, J. F. W.
    Anderson, I. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S371 - S371